(ZION) Zions Bancorporation - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9897011071

ZION: Commercial, Retail, Wealth, Corporate, Financial

Zions Bancorporation, National Association operates as a regional banking powerhouse across 11 Western states, including Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. Through its subsidiaries like Zions Bank, California Bank & Trust, and Amegy Bank, the company offers a comprehensive suite of financial services tailored to individuals and businesses. Its product range spans commercial banking solutions for SMEs, such as lending and cash management, and retail banking services including mortgages and consumer loans. Additionally, Zions provides wealth management and investment banking services, positioning it as a key player in the regional banking sector with a strong commitment to technological innovation and customer-centric service.

Founded in 1873 and headquartered in Salt Lake City, Utah, Zions Bancorporation has established itself as a financially sound institution with a market capitalization of $6.534 billion. The companys strategic focus on digital transformation and community engagement has earned it recognition for its sustainable practices. Zions Bancorporations dedication to excellence is reflected in its consistent financial performance and customer satisfaction awards, solidifying its reputation as a trusted financial partner in the Western United States.

Over the next three months, ZION is expected to experience a slight uptrend with potential resistance near $50, supported by its SMA 20 crossing above the SMA 50. The stocks volatility, indicated by an ATR of 2.42, suggests moderate price fluctuations. Fundamentally, ZIONs attractive P/E ratio of 8.95 and a return on equity of 12.80% highlight its undervaluation and profitability, making it a compelling investment opportunity in the regional banking sector.

Additional Sources for ZION Stock

ZION Stock Overview

Market Cap in USD 6,677m
Sector Financial Services
Industry Banks - Regional
GiC Sub-Industry Regional Banks
IPO / Inception 1990-03-26

ZION Stock Ratings

Growth Rating 33.2
Fundamental 36.5
Dividend Rating 66.3
Rel. Strength -6.31
Analysts 3.19/5
Fair Price Momentum 44.34 USD
Fair Price DCF 68.79 USD

ZION Dividends

Dividend Yield 12m 3.60%
Yield on Cost 5y 6.33%
Annual Growth 5y 4.07%
Payout Consistency 93.3%

ZION Growth Ratios

Growth Correlation 3m -91.4%
Growth Correlation 12m 55.6%
Growth Correlation 5y 14.5%
CAGR 5y 11.11%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m 0.55
Alpha -1.00
Beta 1.449
Volatility 41.25%
Current Volume 1778.3k
Average Volume 20d 1834.8k
What is the price of ZION stocks?
As of April 29, 2025, the stock is trading at USD 44.94 with a total of 1,778,327 shares traded.
Over the past week, the price has changed by +3.03%, over one month by -9.16%, over three months by -21.60% and over the past year by +12.44%.
Is Zions Bancorporation a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Zions Bancorporation (NASDAQ:ZION) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.49 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZION as of April 2025 is 44.34. This means that ZION is currently overvalued and has a potential downside of -1.34%.
Is ZION a buy, sell or hold?
Zions Bancorporation has received a consensus analysts rating of 3.19. Therefor, it is recommend to hold ZION.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 15
  • Sell: 2
  • Strong Sell: 0
What are the forecast for ZION stock price target?
According to ValueRays Forecast Model, ZION Zions Bancorporation will be worth about 47.9 in April 2026. The stock is currently trading at 44.94. This means that the stock has a potential upside of +6.56%.
Issuer Forecast Upside
Wallstreet Target Price 54 20%
Analysts Target Price 58.7 30.6%
ValueRay Target Price 47.9 6.6%